Latest News

Ra Pharmaceuticals Announces Pricing of Public Offering of Common Stock


CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ra Pharmaceuticals, Inc. (Nasdaq: RARX) (“Ra Pharma”) today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock, at a public offering price of $32.50 per share. Ra Pharma also granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are exp

Source link

Related posts

Practical tips for teaching academic integrity in the digital age

Newsemia

Researchers rush to test coronavirus vaccine in people without knowing how well it works in animals

Newsemia

Medical News Today: Depression: Exercise may reduce symptoms but not in women

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World